 |
 |
 |
|
 |
|
 |
 |
 |
Petition to Congress |
 |
|
|
Friday, September 05, 2008 | |||||
A Petition to Congress to Preserve Innovation and Support H.R. 1956, the "Patient Protection and Innovative Biologic Medicines Act of 2007"
- Because the survival rate of childhood cancer has not changed in the last decade.
- Because treatment for children with cancer has not changed significantly in recent years and we are eagerly awaiting a major breakthrough.
- Because current toxic therapies are not a solution for children with cancer as they cause lifelong health problems including second cancers.
- Because biologic products are among the most promising and effective medicines for the treatment of serious and life-threatening diseases, like childhood cancer.
- Because it is vital that we spur innovation for pharmaceutical companies to invest in the development of these life-saving drugs.
We, the undersigned, petition Congress to support H.R. 1956, the “Patient Protection and Innovative Biologic Medicines Act of 2007,” legislation that creates a pathway for “follow-on” biologics but establishes an appropriate balance between reducing cost, ensuring safety and providing incentives for innovation.
The Candlelighters Childhood Cancer Foundation
 |
 |
© 1998-2008, Candlelighters® Childhood Cancer Foundation / Terms of Use